Will, Olga Maria, Purcz, Nicolai, Chalaris, Athena, Heneweer, Carola, Boretius, Susann ORCID: 0000-0003-2792-7423, Purcz, Larissa, Nikkola, Lila, Ashammakhi, Nureddin, Kalthoff, Holger, Glueer, Claus-Christian, Wiltfang, Joerg, Acil, Yahya and Tiwari, Sanjay ORCID: 0000-0002-3804-3300 (2016). Increased survival rate by local release of diclofenac in a murine model of recurrent oral carcinoma. Int. J. Nanomed., 11. S. 5311 - 5322. ALBANY: DOVE MEDICAL PRESS LTD. ISSN 1178-2013

Full text not available from this repository.

Abstract

Despite aggressive treatment with radiation and combination chemotherapy following tumor resection, the 5-year survival rate for patients with head and neck cancer is at best only 50%. In this study, we examined the therapeutic potential of localized release of diclofenac from electrospun nanofibers generated from poly(D, L-lactide-co-glycolide) polymer. Diclofenac was chosen since anti-inflammatory agents that inhibit cyclooxygenase have shown great potential in their ability to directly inhibit tumor growth as well as suppress inflammation-mediated tumor growth. A mouse resection model of oral carcinoma was developed by establishing tumor growth in the oral cavity by ultrasound-guided injection of 1 million SCC-9 cells in the floor of the mouth. Following resection, mice were allocated into four groups with the following treatment: 1) no treatment, 2) implanted scaffolds without diclofenac, 3) implanted scaffolds loaded with diclofenac, and 4) diclofenac given orally. Small animal ultrasound and magnetic resonance imaging were utilized for longitudinal determination of tumor recurrence. At the end of 7 weeks following tumor resection, 33% of mice with diclofenac-loaded scaffolds had a recurrent tumor, in comparison to 90%-100% of the mice in the other three groups. At this time point, mice with diclofenac-releasing scaffolds showed 89% survival rate, while the other groups showed survival rates of 10%-25%. Immunohistochemical staining of recurrent tumors revealed a near 10-fold decrease in the proliferation marker Ki-67 in the tumors derived from mice with diclofenac-releasing scaffolds. In summary, the local application of diclofenac in an orthotopic mouse tumor resection model of oral cancer reduced tumor recurrence with significant improvement in survival over a 7-week study period following tumor resection. Local drug release of anti-inflammatory agents should be investigated as a therapeutic option in the prevention of tumor recurrence in oral squamous carcinoma.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Will, Olga MariaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Purcz, NicolaiUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Chalaris, AthenaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Heneweer, CarolaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Boretius, SusannUNSPECIFIEDorcid.org/0000-0003-2792-7423UNSPECIFIED
Purcz, LarissaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Nikkola, LilaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Ashammakhi, NureddinUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Kalthoff, HolgerUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Glueer, Claus-ChristianUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Wiltfang, JoergUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Acil, YahyaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Tiwari, SanjayUNSPECIFIEDorcid.org/0000-0002-3804-3300UNSPECIFIED
URN: urn:nbn:de:hbz:38-289011
DOI: 10.2147/IJN.S109199
Journal or Publication Title: Int. J. Nanomed.
Volume: 11
Page Range: S. 5311 - 5322
Date: 2016
Publisher: DOVE MEDICAL PRESS LTD
Place of Publication: ALBANY
ISSN: 1178-2013
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
SQUAMOUS-CELL CARCINOMA; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; COLORECTAL-CANCER; PREVENTION; HEAD; NECK; CELECOXIB; SURGERY; INHIBITION; EFFICACYMultiple languages
Nanoscience & Nanotechnology; Pharmacology & PharmacyMultiple languages
Refereed: Yes
URI: http://kups.ub.uni-koeln.de/id/eprint/28901

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item